US1167941087 - BRKR - 813534 (XNAS)
BRUKER CORP Aktie
68,26 USD
Aktuelle Kurse von BRUKER CORP
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
BRKR
|
USD
|
19.09.2024 22:00
|
68,26 USD
| 66,80 USD | 2,19 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 3,96 % | 6,26 % | 2,20 % | -25,80 % | 4,50 % | 56,81 % |
Firmenprofil zu BRUKER CORP Aktie
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Investierte Fonds
Folgende Fonds haben in BRUKER CORP investiert:
Fonds | Vol. in Mio 289,21 | Anteil (%) 0,52 % |
Unternehmensdaten zur BRUKER CORP Aktie
Name BRUKER CORP
Firma Bruker Corporation
Symbol BRKR
Website https://www.bruker.com
Heimatbörse
NASDAQ
WKN 813534
ISIN US1167941087
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Dr. Frank H. Laukien Ph.D.
Marktkapitalisierung 10 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 9,7 T
Adresse 40 Manning Road, 01821 Billerica
IPO Datum 2000-08-04
Dividenden von BRUKER CORP
Ex-Datum | Dividende pro Aktie |
---|---|
30.08.2024 | 0,05 USD |
03.06.2024 | 0,05 USD |
29.02.2024 | 0,05 USD |
30.11.2023 | 0,05 USD |
31.08.2023 | 0,05 USD |
31.05.2023 | 0,05 USD |
28.02.2023 | 0,05 USD |
30.11.2022 | 0,05 USD |
31.08.2022 | 0,05 USD |
31.05.2022 | 0,05 USD |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | BKD.F |
NASDAQ | BRKR |
Weitere Aktien
Investoren die BRUKER CORP halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024